Just the Facts: Recce Pharmaceuticals scores 93% efficacy in Phase II trial

By Proactive Investors / February 17, 2025 / www.youtube.com / Article Link

Recce Pharmaceuticals Ltd has received positive Phase II clinical trial results for RECCE(R) 327 Topical Gel (R327G) in treating ...

Recent News

Mixed outlook for gold as it remains range bound for past three months

June 30, 2025 / www.canadianminingreport.com

Gold stocks down on flat metal price

June 30, 2025 / www.canadianminingreport.com

Gold stocks down on metal decline

June 23, 2025 / www.canadianminingreport.com

Huge quantifiable rise in geopolitical, economic and trade risks

June 23, 2025 / www.canadianminingreport.com

Platinum clearly ahead of palladium for first time in seven years

June 16, 2025 / www.canadianminingreport.com

See all >